Knight Ridder/Tribune Business News - Beleaguered Mylan Laboratories wins drug approvals.
By Alana Semuels, Pittsburgh Post-Gazette Knight Ridder/Tribune Business News
Aug. 24–Mylan Laboratories shook off a shaky two weeks yesterday with some good news — the Food and Drug Administration granted final approval yesterday for a generic version of the hypertension drug Lopressor and tentative approval of Pfizer’s popular allergy and depression medications Zyrtec and Zoloft.
Related Results
Some anti-hypertension drugs increase rate of sudden death - adapted from the…
When are beta blockers the right hypertension drug? Beta blockers are critica…
Beta-blockers can be heart health lifesavers: these drugs can help restore no…
Hypertensive drug classes: brand names only
FDA First-time generics approvals–2004.(RX Special Report)
Although Zoloft generated $3.12 billion in sales last year and Zyrtec generated $1.34 billion, Mylan cannot launch generic versions of these two drugs until 2007 and 2006, respectively. Mylan …
Read the rest of this article with a Free Trial at HighBeam Research.
